On the afternoon of 20th April, 2024, Zhejiang Hisun Animal Healthcare Products Co., Ltd. (hereinafter referred to as "Hisun Animal Healthcare") held a new product launch event for Yunyuanqing (Porcine Circovirus Type 2 and Swine Mycoplasma Hyopneumoniae Vaccine, Inactivated (Recombinant Baculovirus Strain DBN01+Strain DJ-166)) in Hangzhou, Zhejiang province. Experts, scholars, distributors, husbandry groups, and industry media jointly witnessed the launch. This conference was lively broadcasted by Xinzhupai and Powerpigs, attracting 120,000 people to watch online at the same time.

PART-01 Opening Ceremony, Shining New Chapter

"Yunyuanqing", as the first blockbuster product in the vaccine field of Hisun Animal Healthcare, after seven years of dedicated research and development, the vaccine has completed over 120,000 head trials and has been proven effective in more than 100 pig farms. This launch marks the realization of Hisun Animal Healthcare's “Chemical Drug + Vaccine” dual-wheel drive development, providing closed-loop protection for animal’s health throughout the entire life cycle.

Shen Xifei, Chairman of Hisun Animal Healthcare, delivered the opening speech at this meeting, he stated that Hisun Animal Healthcare completed its wholly-owned control of Yunnan Biological Pharmaceutical in 2021, since then we have formally laid out the vaccine industry, during the same period, we have focused on investing in infrastructure, talent cultivation, production and quality standards, research and development reserves, and other aspects. Yunyuanqing, as the first blockbuster product in the field of Hisun Animal Healthcare vaccines, has been taken seven years of dedicated research and development. In the future, we will steadfastly achieve the coordinated development of chemical drugs and vaccines, providing full life-cycle protection for animal health.

PART-02 Planning and Leading for Future

Ji Wei, General Manager of Hisun Animal Healthcare and Executive Director of Yunnan Biological Pharmaceutical, introduced that Yunyuanqing is Hisun Animal Healthcare's first blockbuster swine vaccine product, our long-term goal is to promote the coordinated development of chemical drugs and vaccines, and to adhere to long-term principles in order to break free from fierce domestic competition. He stated that the planning of Hisun Animal Healthcare vaccine is divided into three steps, the first step is to make up for the existing vaccines in the market as the cornerstone of the vaccine product line; The second step is to further open up the market through the research and development of advantageous technology products; The third step is to lead the animal vaccine industry with innovative technology.

With the recognition by many swine farms for the Yunyuanqing, we are full of confidence in the future prospects of Yunyuanqing. Hisun Animal Healthcare believes that by solving practical problems for end customers through solutions and services, it can bring value to customers, and good products always have opportunities.

PART-03 R&D Sharing Professional Analysis

Zhou Yongqi, the R&D Director of Hisun Animal Healthcare Vaccine Division, shared the R&D process and said that there are many diseases that cannot be prevented by relying on vaccine immunization, however, Yunyuanqing is expected to truly create a combined vaccine that can alleviate the pressure of circovirus and mycoplasma infections for farmers.

Zhou Yang, Product Manager of Hisun Animal Healthcare Vaccine Division, introduced the characteristics of the Yunyuanqing, stating that with the strong research and development capabilities of Hisun Pharma, Yunyuanqing adopts high-density fermentation and cultivation technology to achieve a significant increase in mycoplasma antigen content; Cap proteins are concentrated by 50KD ultrafiltration and affinity chromatography process, only VLPs protein remained; Nano water adjuvant assists to provide solid protection. Supported by triple technological advantages, Yunyuanqing has been reliably proven in over 100 large-scale pig farms.

PART-04 Expert Provides Support

Zhou Bin, Director, Professor, PhD, and Doctoral Supervisor of the Department of Preventive Veterinary Medicine at the College of Veterinary Medicine, Nanjing Agricultural University, shared a theme report on "The Epidemic and Prevention and Control of Porcine Circovirus Disease and Mycoplasma Pneumonia", comprehensively analyzed the pathogenic characteristics, epidemic situation, and disease hazards.

Feng Zhixin, Deputy Director and Researcher of the Institute of Animal Sciences of Jiangsu Academy of Agricultural Sciences, and Chief Scientist of the Animal Mycoplasma Innovation Team, shared the theme report "Exploration of Key Technologies for Prevention and Control of Porcine Respiratory Diseases", analyzed and summarized the pathogenesis, prevention and control strategies of Porcine Respiratory Diseases.

Li Jinlong, Dean, Professor, and Doctoral Supervisor of the College of Veterinary Medicine at Northeast Agricultural University, shared a theme report on the "Global Epidemic Situation of Swine Diseases and the Current Status of Prevention and Control of Circovirus", discussed the prevention and control of circovirus and mycoplasma from the internal details of pig farms.

Hisun Animal Healthcare has been constantly transforming and growing, the launch of Yunyuanqing will not only further supplement product line and structure of Hisun Animal Healthcare, but also help to improve the strategic layout in the veterinary healthcare sector. In the future, we will always adhere to building a leading brand in the domestic animal healthcare industry, take the new domestic product route of "Hisun Quality", use Chemical Drug + Vaccine to create full life cycle protection for animals. Innovation, for animal, for health, for you.